KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Goodwill & Intangibles: 2019-2021

Historic Goodwill & Intangibles for Royalty Pharma (RPRX) over the last 3 years, with Dec 2021 value amounting to $5.7 million.

  • Royalty Pharma's Goodwill & Intangibles was N/A to $924.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $924.6 million, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2021, which is 80.22% down from last year.
  • According to the latest figures from FY2021, Royalty Pharma's Goodwill & Intangibles is $5.7 million, which was down 80.22% from $28.7 million recorded in FY2020.
  • Over the past 5 years, Royalty Pharma's Goodwill & Intangibles peaked at $51.7 million during FY2019, and registered a low of $5.7 million during FY2021.
  • In the last 3 years, Royalty Pharma's Goodwill & Intangibles had a median value of $28.7 million in 2020 and averaged $28.7 million.
  • Data for Royalty Pharma's Goodwill & Intangibles shows a maximum YoY plummeted of 80.22% (in 2021) over the last 5 years.
  • Yearly analysis of 3 years shows Royalty Pharma's Goodwill & Intangibles stood at $51.7 million in 2019, then slumped by 44.58% to $28.7 million in 2020, then tumbled by 80.22% to $5.7 million in 2021.